Our System “Connected Health”

¿WHAT IS?

Innovative technology solutions to solve global public health problems using a connected diagnosis platform for diseases affecting millions of people around the world.

It is a low cost technology based on an intelligent platform what integrates Neural Networks, Fuzzy Logic and Expert Systems and able to diagnose multiples diseases in real time. A platform it could be operated by any user, without the supervision of a specialist.

¿HOW DOES IT WORK?

Through our cloud based expert system our platform can be accessed from any location and at a very low cost. Users can connect local devices or gain connectivity to remote devices at other facilities. Access is immediate without typical delays of conventional health systems. This system will allow facilities to share experts, equipment, while improving patient outcomes esp. In areas where access to traditional health systems is difficult, expensive or non existent. The patient benefits not only from it’s affordable cost but from immediate “on-demand” health assessments covering a wide range of pathologies, such as cancer, diabetes, and a broad range of diagnostic tools like x-rays, and many other


¿WHAT ARE KEY BENEFITS?

This system can detect and diagnose different diseases with a low cost almost anywhere on the planet without the presence of a specialist doctor, giving medicine to the most vulnerable population
This system frees resources on traditional health systems that take up much time and money on disease detection, allowing you to use these resources more efficiently like treatments and surgeries

See some more features

What else we provide?

Global coverage

Global coverage using telecommunications systems such as the Internet and data transmission via satellite.

 

Open Source

Free and Open Source Software (FOSS) is a philosophy of shared abundance and mutual development leading to affordable, robust and secure technology . MHT is an open source system system based on this philosophy.  Life is to precious to be left to expensive closed systems which increase costs and delay treatment. We provide access to our system in the form of a double-side market. We support both the medical community and all patients.

Development

Develop creative solutions using the synergic benefits of of high technology and low cost digital scaling to meet the needs of the global medical community while disrupting illness to improve patients health.

 

Do you want to…

Learn About Our First Release?

Take some time and meet our Co-Founders?

...TL;DR Medical Facts You Need To Know

Who we are?

Rafael Bueno, a “research oriented” ophthalmologist, and Alvaro Rios, a 100% “Geek” engineer, who have pooled their expertise to develop a connected diagnosis platform for diseases using innovative technologies. Rafael & Alvaro are working to disrupt illness by solving critical issues facing public health outcomes globally.

Rios and Bueno are building Medical High Tech (MHT) whose mission is to disrupt illness by disrupting the high cost of specialist diagnostics. Fast and affordable diagnostics means early and more affordable treatments to enable a new era in the therapeutic management and improved patients outcomes.

  • The first release of MHT technology is a system for “screening" of diabetic retinopathy.
  • The MHT`s system is designed to help the +10% of the world’s population affected by diabetes; a pandemic which impacts up to 20% of the adult population (aged 40 to 80 years).
  • Future plans for MHT is the creation and development of more and improved systems for diagnosis and treatment covering a wider range of diseases.

Our team

Screening of Diabetic Retinopathy – SDR

The first release of MHT technology is a system for “screening" of diabetic retinopathy. It is a low cost intelligent platform able to process and diagnose in real time. The MHT platform could be operated by any user, without the supervision of a specialist.

10%+ of the world’s population affected by diabetes, a pandemic which impacts up to 20% of the adult population (aged 40 to 80 years). The first release of the MHT system MHT`s system is designed to help this cohort.

At ARVO’15, Rios and Bueno presented to the scientific community their work “Screening of Diabetic Retinopathy: Our experience Using Telemedicine Method”. At this event, Rios & Bueno reaffirmed their mission to improve the quality of life for people on global scale.

To achieve its social mission MTH proposes distributing their technology through public and private medical institutions as well as pharmacies and other established medical channels to insure they can reach the entire population. The ultimate goal for MHT is to make its massive diagnostic platform affordably accessible to the entire global population. MHT seeks to improve access and outcomes for all stakeholders especially low-income stakeholders that rarely have access to medical care. MHT will reduce diagnosis costs and reduce financial pressures on local and regional health care systems. They believe reduced costs for specialist diagnosis will mitigate an increasing share of the financial burden facing all global medical providers significantly reducing the risk of financial collapse.

DIABETES STATS

In 2014, 422 million people in the world had diabetes – a prevalence of
8%
All deaths due to high blood glucose occur before the age of 70
43%
Diabetes was listed as the primary cause of kidney failure of all new cases in 2011 in
44%
Adults with diabetes aged 40 years or older with diabetic retinopathy
28%
Millions of women in the all the world with diabetes estimated for the year 2030
222
Diabetes is the ninth leading cause of death in women globally, million deaths per year
2
Most deaths from diabetes in the countries of middle and low income are people under
60
People with diabetes who develop some degree of retinopathy approximately 1 in
3

WANT TO KNOW MORE ABOUT OUR COMPANY? CURIOUS WHAT ELSE WE DO?

About us

Rafael Bueno, an ophthalmologist, and Alvaro Rios, a “Geek” engineer, have pooled their expertise to develop innovative technology solutions to solve global public health problems using a connected diagnosis platform for diseases affecting millions of people around the world.
Currently, Rios and Bueno are working on creating a technology company with a deeply social mission. The company is Medical High Tech (MHT); which has set its mission to enable a new era in the therapeutic management of diseases while improving patients outcomes.

Medical High Tech Video

We are delighted!! MedicalHighTech has been selected to be a part of ALPHA program, 2016!!! , Rise conference Hong Kong, 31st May – 2nd June.

We are pooled our expertise to develop innovative technology solutions to solve global public health problems using a connected diagnosis platform for diseases affecting millions of people around the world.

Our team is working on creating a technology company with a deeply social mission. The company is Medical High Tech (MHT); which has set its mission to enable a new era in the therapeutic management of diseases while improving patients outcomes.

The first release of MHT technology is a system for “screening" of diabetic retinopathy. It is a low cost technology based on an intelligent platform able to diagnose the disease in real time. A platform that could be operated by any user, without the supervision of a specialist.

The MHT`s system is designed to help the +10% of the world’s population affected by diabetes, a pandemic which impacts up to 20% of the adult population (aged 40 to 80 years).

We are looking for business partners and people who want to contribute talent and creativity to this project.

medicalhightech.com

Rise conference

Contact Us

 

Contact person:

 

 

E-mail:

info@medicalhightech.com